Part 1/6:
Soros and Biotech: A Shift in Strategy
With the recent revelation from George Soros’ 13F filing, discussions surrounding his investments have resurfaced, particularly in the biotechnology sector. Kristine Harjes and Todd Campbell delve into the curious moves of the iconic investor, shedding light on his strategies in relation to Gilead Sciences, Novavax, and the biotech ETF, IBB.